Cadrenal Therapeutics Announces Exercise of Warrants for $4.7 Million Gross Proceeds ...Middle East

PONTE VEDRA, Fla., Nov. 1, 2024 /PRNewswire/ -- Cadrenal Therapeutics, Inc., ("Cadrenal" or the "Company") (Nasdaq: CVKD), a biopharmaceutical company developing tecarfarin, a late-stage novel oral and reversible anticoagulant (blood thinner) for certain rare medical conditions, today...

Read More Details
Finally We wish PressBee provided you with enough information of ( Cadrenal Therapeutics Announces Exercise of Warrants for $4.7 Million Gross Proceeds )

Also on site :

• Trump cuts tariffs on U.K. cars, steel and aluminum but keeps 10% base duty while Britain trims its taxes on 2,500 U.S. products
• ‘Shadow Force’ Review: Two Spies Get Dragged From the Cold in Middling Action Opus
• T.J. Maxx Is Selling a Luxury, Line-Smoothing Eye Cream for Less Than $20